Alzheimer's Disease Research Center
Top Stories
-
The goal of the ADRC HS Scholars Program is to reach talented young people from backgrounds underrepresented in science and medicine, and to encourage and inspire them toward careers in these fields.
-
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
-
Dr. James M. Noble is an associate professor of neurology and dementia specialist in the Division of Aging and Dementia.
-
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
Latest News
-
By Dominique Mosbergen
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease.
-
By Corinne Purtill
A recent look inside a baby zebrafish's transparent brain offers clues to how we remember and how we forget.
-
Columbia research seven years in the making highlights potential therapeutic target for neurodegenerative disease
-
By Emily Bobrow
There is a robust market for books that praise our seemingly feeble habits of mind.
-
By By Joseph Walker and Thomas M. Burton
The federal health insurance program may limit who can get the drug, which Biogen priced at $56,000 a year, to limit the financial impact
-
By Meg Dalton
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
-
By Matt Fuchs
After exercising, choose a brain-healthy recovery meal.
-
By Usha Lee McFarling
Other researchers are not convinced that these biomarkers vary by race, primarily because so little Alzheimer’s research has been conducted on Black and Latinx people.
-
By Ted Knutson
It is well established that people who had fewer opportunities to receive education when they were children are at higher risk for Alzheimer’s disease later in life, noted Dr. Jennifer Manly
-
A new study on COVID-19 patients with dementia led by James Noble, MD, MS associate professor of neurology at CUIMC
Pages